250 related articles for article (PubMed ID: 26023863)
1. Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.
Ding Y; Chen X; Qian B; Wu G; He T; Feng J; Gao C; Wang L; Wang J; Li X; Cao M; Peng H; Zhao C; Pan W
Sci Rep; 2015 May; 5():10636. PubMed ID: 26023863
[TBL] [Abstract][Full Text] [Related]
2. Development of a sensitive and specific epitope-blocking ELISA for universal detection of antibodies to human enterovirus 71 strains.
He F; Kiener TK; Lim XF; Tan Y; Raj KV; Tang M; Chow VT; Chen Q; Kwang J
PLoS One; 2013; 8(1):e55517. PubMed ID: 23383215
[TBL] [Abstract][Full Text] [Related]
3. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
4. Enterovirus 71 viral capsid protein linear epitopes: identification and characterization.
Gao F; Wang YP; Mao QY; Yao X; Liu S; Li FX; Zhu FC; Yang JY; Liang ZL; Lu FM; Wang JZ
Virol J; 2012 Jan; 9():26. PubMed ID: 22264266
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel monoclonal antibody reactive against the N-terminal region of Enterovirus 71 VP1 capsid protein.
Lim XF; Jia Q; Chow VT; Kwang J
J Virol Methods; 2013 Mar; 188(1-2):76-82. PubMed ID: 23219932
[TBL] [Abstract][Full Text] [Related]
6. Characterization and specificity of the linear epitope of the enterovirus 71 VP2 protein.
Kiener TK; Jia Q; Lim XF; He F; Meng T; Chow VT; Kwang J
Virol J; 2012 Feb; 9():55. PubMed ID: 22361222
[TBL] [Abstract][Full Text] [Related]
7. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71.
Zhang J; Dong M; Jiang B; Dai X; Meng J
Virus Res; 2012 Aug; 167(2):337-42. PubMed ID: 22659489
[TBL] [Abstract][Full Text] [Related]
8. VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population.
Tan S; Tan X; Sun X; Lu G; Chen CC; Yan J; Liu J; Xu W; Gao GF
J Immunol; 2013 Aug; 191(4):1637-47. PubMed ID: 23863902
[TBL] [Abstract][Full Text] [Related]
9. Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice.
Meng T; Kolpe AB; Kiener TK; Chow VT; Kwang J
PLoS One; 2011; 6(7):e21757. PubMed ID: 21747954
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
11. Serological detection and analysis of anti-VP1 responses against various enteroviruses (EV) (EV-A, EV-B and EV-C) in Chinese individuals.
Gao C; Ding Y; Zhou P; Feng J; Qian B; Lin Z; Wang L; Wang J; Zhao C; Li X; Cao M; Peng H; Rui B; Pan W
Sci Rep; 2016 Feb; 6():21979. PubMed ID: 26917423
[TBL] [Abstract][Full Text] [Related]
12. Non-neutralizing Antibody Responses against VP1 in Enterovirus A, B, C and Rhinovirus A species among Infants and Children in Shanghai.
Ding Y; Rui B; Gao C; Xu M; Wang L; Zhao C; Bai J; Wang J; Xu J; Pan W
Sci Rep; 2018 Apr; 8(1):5455. PubMed ID: 29615683
[TBL] [Abstract][Full Text] [Related]
13. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides.
Foo DG; Alonso S; Phoon MC; Ramachandran NP; Chow VT; Poh CL
Virus Res; 2007 Apr; 125(1):61-8. PubMed ID: 17222936
[TBL] [Abstract][Full Text] [Related]
14. Protection against enterovirus 71 with neutralizing epitope incorporation within adenovirus type 3 hexon.
Tian X; Su X; Li X; Li H; Li T; Zhou Z; Zhong T; Zhou R
PLoS One; 2012; 7(7):e41381. PubMed ID: 22848478
[TBL] [Abstract][Full Text] [Related]
15. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71.
Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H
Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164
[TBL] [Abstract][Full Text] [Related]
16. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies.
Liu Q; Huang X; Ku Z; Wang T; Liu F; Cai Y; Li D; Leng Q; Huang Z
J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991
[TBL] [Abstract][Full Text] [Related]
17. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
18. Immunological evaluation and comparison of different EV71 vaccine candidates.
Chou AH; Liu CC; Chang JY; Lien SP; Guo MS; Tasi HP; Hsiao KN; Liu SJ; Sia C; Wu SC; Lee MS; Hsiao CH; Wang JR; Chow YH; Chong P
Clin Dev Immunol; 2012; 2012():831282. PubMed ID: 23008736
[TBL] [Abstract][Full Text] [Related]
19. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection.
Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM
Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335
[TBL] [Abstract][Full Text] [Related]
20. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).
Thanongsaksrikul J; Srimanote P; Tongtawe P; Glab-Ampai K; Malik AA; Supasorn O; Chiawwit P; Poovorawan Y; Chaicumpa W
Arch Virol; 2018 May; 163(5):1141-1152. PubMed ID: 29356992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
